Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute myeloid leukemia; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with 11q23 Rearrangements
• Acute Myeloid Leukemia with Del
• Acute Myeloid Leukemia with Maturation
• Acute Myeloid Leukemia with Translocation
• Acute Promyelocytic Leukemia
• Monocytic Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) | Phase 2 | Status: COMPLETED | Results posted: 2014-02-06